Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Recruiting · NCT05312671 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 2 | 2026-06-25 | NCT05312671 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genentech, Inc. | 221 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 117 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University: Sibley Memorial Hospital | Washington D.C. | United States | 2 |
| Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center | Baltimore | United States | 5 |